Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy

Status unconfirmed

Conditions studied: Radiation Therapy

In brief

Collect blood samples and associated clinical data prior to and post radiation treatment.

Key facts

Study ID

NCT03142425

Run by

DxTerity Diagnostics

People needed

150

Starts

2017-06-19

Expected to finish

2019-12-01

Last updated by the study team

2019-02-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female patients age 18 or older
• Diagnosed with a primary rectal or esophageal cancer
• Planned radiation therapy to the esophagogastric area to a minimum of 4140 cGy for esophageal/gastroesophageal junction cancer or to pelvis to a minimum of 4500 cGy for rectal cancer as part of clinical care
• Combining chemotherapy is allowed
• ECOG Performance Status 0-2
• Able to provide written informed consent

You may not qualify if…

• Subjects who have received radiation within three (3) months to esophagogastric or pelvic areas prior to consent
• Subjects, who in the opinion of the investigator, may not be able to comply with the requirements of the study

Where it is running

• City of Hope — Duarte, California, United States (enrolling)
• Kaiser Permanente Los Angeles Medical Group — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.